- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07721714
SMILE Surgery in One Eye Compared to Ray Tracing-guided LASIK Surgery in the Fellow Eye
A Prospective Randomized Comparison of SMILE Surgery to Ray Tracing-Guided LASIK Surgery
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Sixty-two near-sighted study participants at Stanford are planned to undergo treatment in this clinical research trial.
This comparison will be made between both eyes of the same study participant following LASIK and SMILE surgery. One eye will have ray tracing-guided LASIK and their fellow eye treated with SMILE surgery. Both ray tracing-guided LASIK surgery and SMILE surgery have been found to be safe, predictable and effective when used for laser vision correction procedures. Both ray tracing-guided LASIK surgery and SMILE surgery used in this study have been approved for laser vision correction by the United States Food and Drug Administration. Standard refractive outcomes such as uncorrected visual acuity (vision without glasses or contact lenses) and best corrected visual acuity (vision with glasses or contact lenses), and intended vs. achieved postoperative refractions (the accuracy of the LASIK and SMILE procedures) will be evaluated.
Randomization:
The choice of which eye receives ray tracing-guided LASIK surgery and which eye receives SMILE surgery will be randomized (assigned at random) prior to enrollment. Participants will have one eye treated with ray tracing-guided LASIK and your other eye treated with the SMILE surgery. Participants will know which eye is being treated with ray tracing-guided LASIK and which eye will be treated with SMILE surgery. Both ray tracing-guided LASIK and SMILE surgery are FDA-approved procedures. Both procedures are being performed according to the FDA-approved labeling. Participants have a fifty percent chance of having their left eye treated with ray tracing-guided LASIK as their right eye (like making a choice by flipping a coin). Participants will undergo bilateral (both eyes at once) surgery.
Screening and Preoperative Assessment Participants will be partially screened via telephone. We will also ask participants to complete screening by coming to the clinic in person. This screening will include measurements of corneal thickness, the shape of the cornea using corneal topography (measures the shape of the front clear surface of the eye), a slit lamp examination of the eye (a microscope to magnify the cornea) and ocular and medical history.
Participants scheduled to undergo LASIK and SMILE surgery for the correction of myopia (nearsightedness) will be screened for eligibility. Eligible participants will be examined preoperatively to establish a baseline for ocular condition (the general health and glasses prescription of the eyes). Postoperatively, participants will undergo an ophthalmic evaluation (complete eye examination) at regular intervals as specified in this protocol. Re-treatments (a second operation on the same eye for residual nearsightedness, farsightedness and/or astigmatism) will not be allowed during the first twelve months of this study. If you elect to undergo a retreatment of your LASIK surgery prior to the 12-month post-operative visit, the data after the retreatment procedure will be excluded from the study analysis.
Participants eyes will be given a thorough examination at each visit. This examination will include the standard elements of a general eye exam including testing of the eye's vision, contrast acuity testing, examination with the slit lamp and the ophthalmoscope to look at the various parts of the eye and a test of the inner eye's pressure.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Fase 4
Contactos e Locais
Contato de estudo
- Nome: Edward E Manche, MD
- Número de telefone: 1-650-498-7020
- E-mail: edward.manche@stanford.edu
Locais de estudo
-
-
California
-
Palo Alto, California, Estados Unidos, 94303
- Recrutamento
- Byers Eye Institute
-
Investigador principal:
- Edward E Manche, MD
-
Contato:
- Edward Manche E Manche, MD
- Número de telefone: 650-498-7020
- E-mail: cornea@stanford.edu
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
Subjects age 22 and older with healthy eyes. Nearsightedness between -1.00 diopters and -8.00 diopters.
Subjects with less than or equal to 3.00 diopters of astigmatism.
Exclusion Criteria:
Subjects under the age of 22. Subjects with excessively thin corneas. Subjects with topographic evidence of keratoconus. Subjects with ectactic eye disorders. Subjects with autoimmune diseases. Subjects who are pregnant or nursing. Subjects must have similar levels of nearsightedness in each eye. They can not be more than 1.5 diopter of difference between eyes.
Subjects with more than 3.00 diopters of astigmatism Subjects must have similar levels of astigmatism in each eye. They can not have more than 0.75 diopters of difference between eyes.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Ray tracing guided LASIK surgery
LASIK
|
LASIK
|
|
Comparador Ativo: SMILE surgery
SMILE
|
LASIK
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in corrected distance visual acuity
Prazo: Three months
|
The primary endpoint will be the gain in lines of corrected distance visual acuity (CDVA) at the postoperative month three follow-up compared with preoperative baseline.
|
Three months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in 5 and 25% low contrast CDVA
Prazo: Three months
|
Change in 5 and 25% low contrast best corrected visual acuity from preoperative to postoperative month three
|
Three months
|
|
Change in patient self reported quality of vision and life
Prazo: Three months
|
Will compare preoperative quality of vision and quality of life as measured by the validated Patient Reported Outcomes With LASIK (PROWL) questionnaire to postoperative month three.
|
Three months
|
|
Corneal epithelial thickness changes
Prazo: Three months
|
Measure corneal epithelial thickness maps preoperatively and compare changes at postoperative month three
|
Three months
|
|
Change in higher order aberrations
Prazo: Three months
|
Will measure preoperative higher order aberrations using wavefront aberrometry and compare to postoperative month three measurements
|
Three months
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 79951
- 359910 (Número de outro subsídio/financiamento: Alcon)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .